|
|
|
|
|
|
|
A New Approach To Isolator Decontamination
|
|
|
How can you address the decontamination challenges associated with isolated fill-finish operations?
New innovations, such as low-concentration Vapor Phase Hydrogen Peroxide, are being implemented to ensure superior sporicidal reduction and operational safety and reduce decontamination cycle time.
|
|
|
|
|
|
|
American-made quality meets worldwide benefit in AST's new fill-finish isolator. Learn about the development process behind this innovative system that's addressing issues in isolator manufacturing and servicing, as well as meeting the needs of the liquid pharmaceutical market.
|
|
|
|
|
In parenteral drug manufacturing, product quality is paramount. A fully integrated barrier solution offers robust defense against air handling challenges, ensuring sterility and viability. Discover how this turnkey technology can elevate your fill-finish process.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
